Please assess the completion status of the following clinical trial:

Trial Title: A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Age at the time of enrollment is:~   * 18 through 55 years (before the fifty sixth birthday) for Group 1.~  * 3 through 5 years (before the sixth birthday) for Group 2.~  * 42 to 98 days for Group 3.~2. Healthy subject as determined by medical history, physical examination, and judgment of the investigator.~Exclusion Criteria:~* Previous vaccination with licensed or investigational pneumococcal vaccine.~* Previous anaphylactic reaction to any vaccine or vaccine-related component.~* Contraindication to vaccination with pneumococcal vaccine.

- Gender: ALL
- Minimum Age: 42 Days
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Group 1 (Type: EXPERIMENTAL): Adults aged 18 through 55 years (before the fifty sixth birthday)
- Group 2 (Type: EXPERIMENTAL): Children aged 3 through 5 years (before the sixth birthday)
- Group 3 (Type: EXPERIMENTAL): Infants aged approximately 2 months (42 to 98 days)

Based on this trial design, predict the completion outcome and termination type (if applicable).